Prot# SHP621-303: A Phase 3, Multicenter, Open-label Continuation Study with Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects with Eosinophilic Esophagitis (EoE)

Project: Research project

Project Details

StatusActive
Effective start/end date3/1/183/1/21

Funding

  • PPD Development (Prot# SHP621-303)
  • Shire Human Genetic Therapies, Inc. (Prot# SHP621-303)